Eocene Ltd. (EOCN) vs Revelation Biosciences, Inc. (REVB)

Eocene Ltd. and Revelation Biosciences, Inc. are both Biotechnology companies. Eocene Ltd. and Revelation Biosciences, Inc. are of similar size ($3.2M and $3.0M). Across the 10 metrics below, Eocene Ltd. leads on 5 and Revelation Biosciences, Inc. on 5.

Valuation

Metric EOCN REVB Biotechnology median
P/E n/m n/m 8.50
P/S 1.33 n/m 9.71
P/B 0.21 0.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.61 0.86 0.64
EV/Sales (3.00) n/m 9.21
Earnings yield (532.63%) (2,564.58%) (33.15%)
Free cash flow yield (314.99%) (513.59%) (25.50%)

Profitability

Metric EOCN REVB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (68.21%) (276.43%) (56.36%)
Return on assets (55.03%) (214.63%) (48.04%)
Return on invested capital (163.19%) 0.00% 0.00%

Growth

Metric EOCN REVB Biotechnology median
Revenue growth (TTM) 87.83% — 6.02%
EPS growth (last fiscal year) 70.42% 97.72% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EOCN REVB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.16 6.21 4.72
Net debt to EBITDA 1.31 1.18 0.96

Dividend

Metric EOCN REVB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EOCN REVB Biotechnology median
Market cap 3.18m 3.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack